Formulation Development White Papers & Articles
-
Doubling Up For Speed In Biomanufacturing
12/12/2025
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
How To Reduce Batch Loss In Biopharma Production
12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
CDMOs - Key Collaborators In Streamlining Drug Development
12/12/2025
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
Scaling Up Bioprocesses Through A CDMO
12/12/2025
Scaling biopharma processes is complex. Learn how flexibility, single-use systems, and strategic partnerships are helping manufacturers overcome these challenges and accelerate time to market.
-
How To Capture Growth In The Expanding Metabolic Drug Market
12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
What's Next In Pharmaceutical R&D?
11/18/2025
Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.
-
How One Biotech Company Is Accelerating The Drug Discovery Workflow
11/14/2025
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Advanced Therapies Going Mainstream: Are We There Yet?
11/14/2025
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
Patient-Centric Formulations In Pediatric Adherence
11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Understanding Adeno-Associated Virus Vector Impurities
11/13/2025
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.